Judith L. Treadway - Concepedia

Author

Judith L. Treadway

Also Known As

J L Treadway, J Treadway, J. L. Treadway, J. Treadway, J.L. Treadway, JUDITH L. TREADWAY, Judith L Treadway, Judith L. Treadway, Judith Treadway, Treadway, J.L.

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)University of Iowa Yale University

About

Judith L. Treadway is an author at Pfizer (United States) specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	31	2K
2	Health Sciences	14	14	963
3	Natural Sciences	11	11	582
4	Public Health	3	3	123
5	Engineering	2	2	157

Judith L. Treadway

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose <i>in vivo</i> William H. Martin, Dennis J. Hoover, Sandra J. Armento, Proceedings of the National Academy of Sciences GlycobiologyMetabolic RemodelingExperimental PharmacologyCp-91149 AdministrationMetabolic Syndrome	1998	230
Astrocyte Glycogen Sustains Neuronal Activity during Hypoglycemia: Studies with the Glycogen Phosphorylase Inhibitor CP-316,819 ([R-R,S]-5-Chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1 H-indole-2-carboxamide) Sang Won Suh, Jennifer P. Bergher, Christopher M. Anderson, Journal of Pharmacology and Experimental Therapeutics	2007	177
Inhibitory Effects of Antipsychotics on Carbachol-Enhanced Insulin Secretion From Perifused Rat Islets David E. Johnson, Hanae Yamazaki, Karen Ward, Diabetes	2005	129
Human liver glycogen phosphorylase inhibitors bind at a new allosteric site Virginia L. Rath, Mark Ammirati, Dennis E. Danley, Chemistry & Biology BiochemistryMedicineLiver PhysiologyNew Allosteric SiteGlycogen Phosphorylase Inhibitors	2000	126
Discovery of (<i>S</i>)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1<i>H</i>-imidazol-1-yl)propanamido)nicotinic Acid as a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus Jeffrey A. Pfefferkorn, Angel Guzmán-Pérez, John Litchfield, Journal of Medicinal Chemistry	2011	114
In Vivo Imaging of Endogenous Pancreatic β-Cell Mass in Healthy and Type 1 Diabetic Subjects Using <sup>18</sup>F-Fluoropropyl-Dihydrotetrabenazine and PET Marc D. Normandin, Kitt Falk Petersen, Yu‐Shin Ding, Journal of Nuclear Medicine	2012	114
Transgenic mice expressing the human GLUT4/muscle-fat facilitative glucose transporter protein exhibit efficient glycemic control. M L Liu, E. Michael Gibbs, Scott C. McCoid, Proceedings of the National Academy of Sciences Glucose HomeostasisTransgenic MiceInsulin SignalingObesityMetabolic Syndrome	1993	104
Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene. Judith L. Treadway, D. M. Hargrove, Nancy A. Nardone, Journal of Biological Chemistry Transgenic Mouse ModelsFree Fatty AcidsGlucose HomeostasisTransgenic MiceCaloric Restriction	1994	102
Indole-2-carboxamide Inhibitors of Human Liver Glycogen Phosphorylase Dennis J. Hoover, Sheri Lefkowitz-Snow, Jana L. Burgess-Henry, Journal of Medicinal Chemistry Cardiovascular PharmacologyAltmetric Attention ScorePharmacotherapyTranslational PharmacologyMolecular Pharmacology	1998	102
Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. Judith L. Treadway, B D Morrison, Maria A. Soos, Proceedings of the National Academy of Sciences EngineeringInsulin SignalingSignaling PathwayReceptor Tyrosine KinaseCell Signaling	1991	102

Page 1